-
What Pigs Revealed that Mice Missed in Huntington’s Disease
9 min read
Latest News
-
How long is too long? Rethinking the Huntington’s disease ‘gray area’
8 min read
Does an ‘intermediate’ CAG repeat count in the Huntington’s disease gene cause brain changes?
-
Can sad mice help treat Huntington's disease?
8 min read
What can we learn about depression symptoms in HD by studying mice – how do you know a mouse is even sad?
-
Gene silencing drug safe in ALS patients… bring on Huntington's disease trials
7 min read
Gene silencing drug injected into spinal fluid in ALS patients proves safe. Good news for similar planned HD trials.
-
A DNA repair protein modifies the stability of long CAG tracts in the Huntington's disease gene
9 min read
DNA repair is a critical process to cells, but errors in this process might explain 'repeat instability' in HD
-
Landmark study puts Huntington's disease trials on TRACK
7 min read
Final results from the TRACK-HD study show very specific changes in HD. We're ready for trials: bring on the drugs!
-
Splicing with danger: a new way of thinking about the harmful Huntington's disease protein
6 min read
Researchers discover a new way harmful fragments of the huntingtin protein are made in neurons.
-
Proposed Huntington's disease 'biomarker' is not useful, new study suggests
7 min read
New study shows a blood chemical called '8OHdG' is not a good biomarker for HD. Bad news?
-
Is access to predictive genetic testing for Huntington's disease a problem?
6 min read
Is access to predictive genetic testing for Huntington's disease a problem? A UBC study says it is.
-
HD Therapeutics Conference 2013 Updates: Day 3
9 min read
Final day of our coverage of the Huntington's Disease Therapeutics Conference 2013
-
HD Therapeutics Conference 2013 Updates: Day 2
6 min read
Day 2 of our coverage of the Huntington's Disease Therapeutics Conference
HDBuzz Trial Tracker
Show 8 more Show less
Updates from the ongoing Phase 3 INVEST-HD trial of votoplam
Updates from the Phase 1b/2a REGEN4HD trial of neural stem cell therapy hNSC-01
Updates from the ongoing Phase 2/3 FALCON-HD trial of SKY-0515
